Dual-miRNA triggered DNA nanomachine for breast cancer subtype detection and treatment

Breast cancer is the most common malignancy in women, posing a serious threat to female health. Due to the high inter- and intra-tumoral heterogeneity of breast cancer, clinical treatment and prognosis can vary greatly in patients.